This map shows the geographic impact of D J Norman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D J Norman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D J Norman more than expected).
This network shows the impact of papers produced by D J Norman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D J Norman. The network helps show where D J Norman may publish in the future.
Co-authorship network of co-authors of D J Norman
This figure shows the co-authorship network connecting the top 25 collaborators of D J Norman.
A scholar is included among the top collaborators of D J Norman based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with D J Norman. D J Norman is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Abramowicz, Daniel, et al.. (1995). OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies.. PubMed. 27(1). 852–3.3 indexed citations
5.
Henell, Karen, Jess Kimball, W C Lye, et al.. (1993). OKT4A (a murine IgG2a anti-CD4 monoclonal antibody) in human organ transplantation: pharmacokinetics and peripheral pharmacodynamics.. PubMed. 25(1 Pt 1). 800–1.2 indexed citations
6.
Batiuk, Thomas D., William M. Bennett, & D J Norman. (1993). Cytokine nephropathy during antilymphocyte therapy.. PubMed. 25(2 Suppl 1). 27–30.19 indexed citations
Norman, D J, Jess Kimball, & J. M. Barry. (1993). Cytokine-release syndrome: differences between high and low doses of OKT3.. PubMed. 25(2 Suppl 1). 35–8.5 indexed citations
9.
Shihab, Fuad S., John M. Barry, & D J Norman. (1993). Encephalopathy following the use of OKT3 in renal allograft transplantation.. PubMed. 25(2 Suppl 1). 31–4.9 indexed citations
10.
Shihab, Fuad S., et al.. (1993). Cytokine-related encephalopathy induced by OKT3: incidence and predisposing factors.. PubMed. 25(1 Pt 1). 564–5.4 indexed citations
11.
Hosenpud, Jeffrey D., Ray E. Hershberger, RANAE RATKOVEC, et al.. (1992). Methotrexate for the treatment of patients with multiple episodes of acute cardiac allograft rejection.. PubMed. 11(4 Pt 1). 739–45.10 indexed citations
Henell, Karen, Szu‐Yi Chou, & D J Norman. (1989). Use of cytomegalovirus-seropositive donor kidneys in seronegative patients: results of prospective serotesting and matching in one center.. PubMed. 21(1 Pt 2). 2082–3.5 indexed citations
Potts, D. Gordon, et al.. (1985). Iohexol Cerebral Angiography. Investigative Radiology. 20(Supplement). S55–S57.8 indexed citations
17.
Kreis, Henri, D J Norman, & P Martín. (1984). Status of monoclonals used therapeutically in transplantation.. PubMed. 16(6). 1655–7.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.